What is Marvel Biosciences Corp.?
, a biotechnology company, develops synthetic chemical derivatives of the original approved drug for the new disease indication in Canada.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
, a biotechnology company, develops synthetic chemical derivatives of the original approved drug for the new disease indication in Canada. The company's lead compound MB-204, a novel fluorinated derivative of istradefylline, an adenosine A2a receptor antagonist to treat alzheimer's disease and autism spectrum disorder, as well as depression and anxiety. The company is listed on the PINK in USA, operating in the Healthcare sector, with a market capitalisation of 6.12M.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.